microDimensions GmbH

microDimensions GmbH specializes in advanced digital pathology solutions, providing innovative software and services that facilitate image analysis and 3D histology reconstruction for medical institutions and laboratories. microDimensions GmbH, founded in 2011 in Munich, Germany, focuses on delivering digital pathology tools. The company has completed 2 deals, with its most recent deal occurring on July 14, 2016. The firm is not noted to have undergone business strategy pivots, nor are there mentions of subsidiaries or parent companies.

Details about the founder are not available. microDimensions offers a suite of integrated software and services tailored for digital pathology applications, focusing on image analysis and 3D histology reconstruction. The company’s core products include Anyslide, a collaborative image-sharing platform; Slidematch, for aligning stained sections; Voloom, for 3D reconstruction of histological sections; and Zoom, a digital pathology viewer. Their solutions cater to laboratories, universities, and medical institutions globally, primarily in Europe, North America, and Asia, enhancing collaboration and accuracy in clinical pathology assessments.

The revenue model of microDimensions is built around subscription-based licensing and partnerships tailored to meet client needs. Clients can choose flexible licensing plans for customized software solutions. Typical transactions involve annual subscription fees that vary based on user volume or service extent. Key offerings such as Anyslide and Slidematch are central to their revenue strategy, supported by collaborations with universities and medical institutions, facilitating both sales and research partnerships.

In July 2016, microDimensions GmbH raised an undisclosed amount of Series A financing led by Dr. Adriaan Hart de Ruijter, with participation from High-Tech Gründerfonds, Bayern Kapital, and a group of business angels. The company plans to expand its product offerings and intends to target new markets in Asia and North America by 2024. Recent funding will be utilized to develop new solutions and enhance the capabilities of existing products, aiming for a stronger foothold in these regions.